Chronic Kidney Disease Flashcards
(39 cards)
Spectrum of pathophysiologic processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR)
Chronic Kidney Disease
2 Broad Sets of Mechanisms of Damage in CKD
- initiating mechanisms specific to the underlying etiology
2. hyperfiltration and hypertrophy of the remaining viable nephrons
Risk Factors of CKD
- small for gestation birth weight
- childhood obesity
- hypertension
- diabetes mellitus
- autoimmune disease
- advanced age
- African ancestry
- a family history of kidney disease
- a previous episode of acute kidney injury and presence of proteinuria
- abnormal urinary sediment
- structural abnormalities of the urinary tract
Normal annual mean decline in GFR with age from the peak GFR (~120 mL/min per 1.73 m2) attained during the 3rd decade of life
~1 mL/min per year per 1.73 m2
Refers to the excretion of amounts of albumin too small to detect by urinary dipstick or conventional measures of urine protein
Microalbuminuria
Serves as a marker not only for early detection of primary kidney disease, but for systemic microvascular disease as well
urinary albumin to creatinine ratio (UACR)
MEN - > 17 mg albumin/g creatinine
WOMEN - > 25 mg albumin/g creatinine
Devised to predict the risk of progression to stage 5 dialysis-dependent kidney disease
Kidney Failure Risk (KFR) equation
Factors affecting the likelihood and rate of CKD progression
baseline eGFR and degree of albuminuria
primary renal disease
ongoing exposure to nephrotoxic agents
others: obesity, hypertension, age, ethnicity and laboratory parameters
Stage of CKD where the accumulation of toxins, fluid, electrolytes normally excreted by the kidney –> uremic syndrome
ESRD
Etiologies of CKD
Diabetic nephropathy Glomerulonephritis HPN associated CKD ADPKD Other cystic and tubulointerstitial nephropathy
Major risk factor for cardiovascular disease
Minor decrement in GFR or the presence of albuminuria
PATHOPHYSIOLOGY OF UREMIC SYNDROME (3 Spheres Of Dysfunction)
- accumulation of toxins that normally undergo renal excretion
- loss of other kidney functions such as fluid and electrolyte homeostasis and hormone regulation
- progressive systemic inflammation and its vascular and nutritional consequences
May serve as an indication to initiate dialysis in advanced CKD
diuretic resistance with intractable edema and hypertension
Common disturbance in advanced CKD – metabolic acidosis
NAGMA – early stage
HAGMA – later stage
Used to maintain euvolemia in CKD
dietary salt restriction and loop diuretics + metolazone
Treatment of hyperkalemia in CKD
dietary restriction of potassium
Kaliuretic diuretics
potassium-binding resins – calcium resonium, sodium polystyrene or patiromer
Considered a uremic toxin and high levels are associated with muscle weakness, fibrosis of cardiac muscle, and nonspecific constitutional symptoms
parathyroid hormone
Leading cause of morbidity and mortality in patients at every stage of CKD
cardiovascular abnormalities
Cardiovascular abnormalities
Ischemic Vascular Disease
Heart Failure
Hypertension and Left Ventricular Hypertrophy
Pericardial Disease
For the CKD patient not yet on dialysis or the patient treated with peritoneal dialysis
oral iron supplementation
Subtle clinical manifestations of uremic NEUROMUSCULAR disease usually become evident at
stage 3 CKD
PERIPHERAL NEUROPATHY becomes clinically evident after the patient reaches
stage 4 CKD
EARLY MANIFESTATIONS OF CNS COMPLICATIONS:
mild disturbances in memory and concentration and sleep disturbance
LATER STAGES:
neuromuscular irritability – hiccups, cramps, and twitching